← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #1859 OF 1,918 MOST-CITED

Suitable size, construction, etc.

FDA cited this observation 5 times across 5 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics5
BY FISCAL YEAR
FY20172
FY20163

How FDA worded it — real examples

Failure to provide facilities of suitable size, construction and location so as to facilitate adequate cleaning, maintenance and proper operations.

Octapharma Plasma Inc. · Maple Heights, Ohio · Biologics · 2017-03-02

Failure to provide facilities of suitable construction so as to facilitate adequate cleaning, maintenance and proper operations.

Kedplasma LLC · Hot Springs, Arkansas · Biologics · 2016-11-21

Failure to provide facilities of suitable construction so as to facilitate adequate cleaning, maintenance and proper operations.

Richmond University Medical Center · Staten Island, New York · Biologics · 2016-08-12

Failure to provide facilities of suitable construction so as to facilitate adequate cleaning, maintenance and proper operations.

St. Mary's Regional Hospital · Grand Junction, Colorado · Biologics · 2016-08-05

Failure to provide facilities of suitable size, construction and location so as to facilitate adequate cleaning, maintenance and proper operations.

Elmhurst Hospital Center · Elmhurst, New York · Biologics · 2016-06-24

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →